Consumer Law

Senator Sanders: FDA Should Allow Cheaper Version of $375K Drug

U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.

Read the source article at reuters.com

    Back to top button